Stages of Parkinson's disease (PD) and the biomarkers of interest. The... | Download Scientific Diagram
Frontiers | Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson's Disease
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms
Disentangling prodromal from non-prodromal symptoms of Parkinson's disease - MDS Abstracts
Parkinson's disease: connecting mitochondria to inflammasomes: Trends in Immunology
Can detection and prediction models for... | Open Research Europe
Parkinson's disease - The Lancet
An early diagnosis is not the same as a timely diagnosis of Parkinson's disease[version 1; referees: 2 approved]
Diagnostic biomarkers for Parkinson's disease at a glance: where are we? | SpringerLink
.jpg "Parkinsons Disease - Course, Natural History and Prognosis - Neurotorium")
Parkinsons Disease - Course, Natural History and Prognosis - Neurotorium
Prognostic biomarkers of Parkinson's disease in the Spanish EPIC cohort: a multiplatform metabolomics approach | npj Parkinson's Disease
Update of the MDS research criteria for prodromal Parkinson's disease - Heinzel - 2019 - Movement Disorders - Wiley Online Library
Frontiers | Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease | ACS Chemical Neuroscience
Cureus | The Correlation Between Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review | Article
PDF) Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts
Frontiers | The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Advances in markers of prodromal Parkinson disease | Nature Reviews Neurology
Frontiers | Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
Parkinson's progression prediction using machine learning and serum cytokines | npj Parkinson's Disease
Progress towards therapies for disease modification in Parkinson's disease - The Lancet Neurology
New hopes for disease modification in Parkinson's Disease - ScienceDirect
Prodromal Parkinson's disease: hype or hope for disease-modification trials? | Translational Neurodegeneration | Full Text
Prodromal Parkinson's disease: hype or hope for disease-modification trials? | Translational Neurodegeneration | Full Text
Prodromal PD: A new nosological entity - ScienceDirect
Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 - Journal of Neurochemistry - Wiley Online Library
